Neri et al. (2011) showed that inhibition of the 26S proteasome impaired homologous recombination-mediated repair of DNA damage in MM cells, resulting in synthetic lethality when combined with PARP inhibitors [40]. This evidence concerns the gene PARP1 and Miyoshi myopathy.